Correlation between anterior chamber flare changes and diabetic macular edema after intravitreal injection of ranibizumab and aflibercept
ConclusionsFlare value changes in patients treated with IVR decreased at day 14 post-injection. This may indicate when the most anti-inflammatory effect was obtained. There was no correlation between changes in flare values and CMT either in the IVA or IVR group; nevertheless, our research suggests that the baseline flare value is a predictive factor for the efficacy of IVA in DME.
Source: Japanese Journal of Ophthalmology - Category: Opthalmology Source Type: research
More News: Diabetes | Endocrinology | Eyes | Japan Health | Lucentis | Opthalmology | Ranibizumab Injection | Study